Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 264

    1.

    Synthesis of carbon-11-labeled 4-aryl-4H-chromens as new PET agents for imaging of apoptosis in cancer.

    Gao M, Wang M, Miller KD, Hutchins GD, Zheng QH.

    Appl Radiat Isot. 2010 Jan;68(1):110-6. Epub 2009 Sep 26.PMID: 19818636 [PubMed - in process]Related articles

    2.

    The Forage and Grain of MON 87460, a Drought-Tolerant Corn Hybrid, Are Compositionally Equivalent to That of Conventional Corn.

    Harrigan GG, Ridley WP, Miller KD, Sorbet R, Riordan SG, Nemeth MA, Reeves W, Pester TA.

    J Agric Food Chem. 2009 Sep 24. [Epub ahead of print]PMID: 19778059 [PubMed - as supplied by publisher]Related articles

    3.

    The role of vascular endothelial growth factor genetic variability in cancer.

    Schneider BP, Radovich M, Miller KD.

    Clin Cancer Res. 2009 Sep 1;15(17):5297-302. Epub 2009 Aug 25.PMID: 19706811 [PubMed - in process]Related articles

    4.

    Synthesis of carbon-11 labeled celecoxib derivatives as new candidate PET radioligands for imaging of inflammation.

    Gao M, Wang M, Miller KD, Hutchins GD, Zheng QH.

    Appl Radiat Isot. 2009 Nov;67(11):2019-24. Epub 2009 Aug 3.PMID: 19683453 [PubMed - in process]Related articles

    5.

    Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies.

    Warner MG, Grate JW, Tyler A, Ozanich RM, Miller KD, Lou J, Marks JD, Bruckner-Lea CJ.

    Biosens Bioelectron. 2009 Sep 15;25(1):179-84. Epub 2009 Jun 26.PMID: 19643593 [PubMed - in process]Related articles

    6.

    Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.

    Wang M, Mickens J, Gao M, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

    Steroids. 2009 Nov;74(12):896-905. Epub 2009 Jun 25.PMID: 19559719 [PubMed - in process]Related articles

    7.

    Inhibitory stabilization of the cortical network underlies visual surround suppression.

    Ozeki H, Finn IM, Schaffer ES, Miller KD, Ferster D.

    Neuron. 2009 May 28;62(4):578-92.PMID: 19477158 [PubMed - indexed for MEDLINE]Related articles

    8.

    Equalization of ocular dominance columns induced by an activity-dependent learning rule and the maturation of inhibition.

    Toyoizumi T, Miller KD.

    J Neurosci. 2009 May 20;29(20):6514-25.PMID: 19458222 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Renewable surface fluorescence sandwich immunoassay biosensor for rapid sensitive botulinum toxin detection in an automated fluidic format.

    Grate JW, Warner MG, Ozanich RM Jr, Miller KD, Colburn HA, Dockendorff B, Antolick KC, Anheier NC Jr, Lind MA, Lou J, Marks JD, Bruckner-Lea CJ.

    Analyst. 2009 May;134(5):987-96. Epub 2009 Mar 5.PMID: 19381395 [PubMed - in process]Related articles

    10.

    Balanced amplification: a new mechanism of selective amplification of neural activity patterns.

    Murphy BK, Miller KD.

    Neuron. 2009 Feb 26;61(4):635-48.PMID: 19249282 [PubMed - indexed for MEDLINE]Related articles

    11.

    A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.

    Mina L, Krop I, Zon RT, Isakoff SJ, Schneider CJ, Yu M, Johnson C, Vaughn LG, Wang Y, Hristova-Kazmierski M, Shonukan OO, Sledge GW, Miller KD.

    Invest New Drugs. 2009 Feb 13. [Epub ahead of print]PMID: 19214387 [PubMed - as supplied by publisher]Related articles

    12.

    Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.

    Ademuyiwa FO, Miller KD.

    Clin Breast Cancer. 2008 Dec;8 Suppl 4:S151-6. Review.PMID: 19158035 [PubMed - indexed for MEDLINE]Related articles

    13.

    Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype.

    Cao M, Liang Y, Shen C, Miller KD, Stantz KM.

    IEEE Trans Med Imaging. 2009 Jun;28(6):861-71. Epub 2009 Jan 13.PMID: 19150783 [PubMed - indexed for MEDLINE]Related articles

    14.

    Medical issues in cancer survivors--a review.

    Miller KD, Triano LR.

    Cancer J. 2008 Nov-Dec;14(6):375-87. Review.PMID: 19060602 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cancer survivors, late and long-term issues.

    Miller KD.

    Cancer J. 2008 Nov-Dec;14(6):358-60. No abstract available. PMID: 19060599 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

    Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD; ECOG 2100.

    J Clin Oncol. 2008 Oct 1;26(28):4672-8. Erratum in: J Clin Oncol. 2009 Jun 20;27(18):3070. PMID: 18824714 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Safety assessment of SDA soybean oil: results of a 28-day gavage study and a 90-day/one generation reproduction feeding study in rats.

    Hammond BG, Lemen JK, Ahmed G, Miller KD, Kirkpatrick J, Fleeman T.

    Regul Toxicol Pharmacol. 2008 Dec;52(3):311-23. Epub 2008 Aug 31.PMID: 18804141 [PubMed - indexed for MEDLINE]Related articles

    18.

    Redefining the target again: chemotherapeutics as vascular disrupting agents?

    Gokmen-Polar Y, Miller KD.

    Cancer Cell. 2008 Sep 9;14(3):195-6.PMID: 18772108 [PubMed - indexed for MEDLINE]Related articles

    19.

    Construction and screening of antigen targeted immune yeast surface display antibody libraries.

    Miller KD, Pefaur NB, Baird CL.

    Curr Protoc Cytom. 2008 Jul;Chapter 4:Unit4.7. Review.PMID: 18770649 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical-translational approaches to the Nm23-H1 metastasis suppressor.

    Steeg PS, Horak CE, Miller KD.

    Clin Cancer Res. 2008 Aug 15;14(16):5006-12. Review.PMID: 18698018 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Breast sentinel lymph node dissection before preoperative chemotherapy.

    Grube BJ, Christy CJ, Black D, Martel M, Harris L, Weidhaas J, Digiovanna MP, Chung G, Abu-Khalaf MM, Miller KD, Higgins SA, Philpotts L, Tavassoli FA, Lannin DR.

    Arch Surg. 2008 Jul;143(7):692-9; discussion 699-700.PMID: 18645113 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Probing feature selectivity of neurons in primary visual cortex with natural stimuli.

    Sharpee T, Sugihara H, Kurgansky AV, Rebrik S, Stryker MP, Miller KD.

    Proc Soc Photo Opt Instrum Eng. 2004;(5467):212-222.PMID: 18633451 [PubMed]Related articlesFree article

    23.

    Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.

    Dickler MN, Cobleigh MA, Miller KD, Klein PM, Winer EP.

    Breast Cancer Res Treat. 2009 May;115(1):115-21. Epub 2008 May 22.PMID: 18496750 [PubMed - indexed for MEDLINE]Related articles

    24.

    Synthesis of new carbon-11 labeled naphthalene-sulfonamides for PET imaging of human CCR8.

    Wang M, Cooley B, Gao M, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

    Appl Radiat Isot. 2008 Oct;66(10):1406-13. Epub 2008 Mar 20.PMID: 18455923 [PubMed - indexed for MEDLINE]Related articles

    25.

    Immobilization strategies for single-chain antibody microarrays.

    Seurynck-Servoss SL, Baird CL, Miller KD, Pefaur NB, Gonzalez RM, Apiyo DO, Engelmann HE, Srivastava S, Kagan J, Rodland KD, Zangar RC.

    Proteomics. 2008 Jun;8(11):2199-210.PMID: 18452230 [PubMed - indexed for MEDLINE]Related articles

    26.

    One-dimensional dynamics of attention and decision making in LIP.

    Ganguli S, Bisley JW, Roitman JD, Shadlen MN, Goldberg ME, Miller KD.

    Neuron. 2008 Apr 10;58(1):15-25. Review.PMID: 18400159 [PubMed - indexed for MEDLINE]Related articles

    27.

    Simple synthesis of carbon-11 labeled styryl dyes as new potential PET RNA-specific, living cell imaging probes.

    Wang M, Gao M, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

    Eur J Med Chem. 2009 May;44(5):2300-6. Epub 2008 Mar 7.PMID: 18396357 [PubMed - indexed for MEDLINE]Related articles

    30.

    On the importance of static nonlinearity in estimating spatiotemporal neural filters with natural stimuli.

    Sharpee TO, Miller KD, Stryker MP.

    J Neurophysiol. 2008 May;99(5):2496-509. Epub 2008 Mar 19.PMID: 18353910 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

    Burstein HJ, Elias AD, Rugo HS, Cobleigh MA, Wolff AC, Eisenberg PD, Lehman M, Adams BJ, Bello CL, DePrimo SE, Baum CM, Miller KD.

    J Clin Oncol. 2008 Apr 10;26(11):1810-6. Epub 2008 Mar 17.PMID: 18347007 [PubMed - indexed for MEDLINE]Related articles

    32.

    Development of new targeted therapies for breast cancer.

    Doyle DM, Miller KD.

    Cancer Treat Res. 2008;141:119-34. Review. No abstract available. PMID: 18274086 [PubMed - indexed for MEDLINE]Related articles

    33.

    Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer.

    Gao M, Wang M, Miller KD, Sledge GW, Zheng QH.

    Eur J Med Chem. 2008 Oct;43(10):2211-9. Epub 2008 Jan 11.PMID: 18272256 [PubMed - indexed for MEDLINE]Related articles

    34.

    Development of new targeted therapies for breast cancer.

    Doyle DM, Miller KD.

    Breast Cancer. 2008;15(1):49-56.PMID: 18224395 [PubMed - indexed for MEDLINE]Related articles

    35.

    Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors.

    Gao M, Wang M, Mock BH, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

    Appl Radiat Isot. 2008 Apr;66(4):523-9. Epub 2007 Nov 19.PMID: 18155914 [PubMed - indexed for MEDLINE]Related articles

    36.

    Antiangiogenic agents in breast cancer.

    Salter JT, Miller KD.

    Cancer Invest. 2007 Oct;25(7):518-26. Review. No abstract available. PMID: 18027149 [PubMed - indexed for MEDLINE]Related articles

    37.

    Synthesis of carbon-11 labeled biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues as new potential PET glioma tumor imaging agents.

    Wang M, Gao M, Miller KD, Sledge GW, Zheng QH.

    Appl Radiat Isot. 2007 Oct;65(10):1152-9. Epub 2007 May 31.PMID: 17604635 [PubMed - indexed for MEDLINE]Related articles

    38.

    RA8, a human anti-CD25 antibody against human Treg cells.

    Arias RS, Flanagan ML, Miller KD, Nien YC, Hu P, Gray D, Khawli LA, Epstein AL.

    Hybridoma (Larchmt). 2007 Jun;26(3):119-30.PMID: 17600493 [PubMed - indexed for MEDLINE]Related articles

    39.

    Effects of inhibitory gain and conductance fluctuations in a simple model for contrast-invariant orientation tuning in cat V1.

    Palmer SE, Miller KD.

    J Neurophysiol. 2007 Jul;98(1):63-78. Epub 2007 May 16.PMID: 17507506 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Comparison of Computational Algorithms for the Classification of Liver Cancer using SELDI Mass Spectrometry: A Case Study.

    Shen C, Breen TE, Dobrolecki LE, Schmidt CM, Sledge GW, Miller KD, Hickey RJ.

    Cancer Inform. 2007 Dec 11;3:329-39.PMID: 19455252 [PubMed - in process]Related articlesFree article

    41.

    Synthesis of carbon-11 labeled sulfonanilide analogues as new potential PET agents for imaging of aromatase in breast cancer.

    Wang M, Lacy G, Gao M, Miller KD, Sledge GW, Zheng QH.

    Bioorg Med Chem Lett. 2007 Jan 15;17(2):332-6. Epub 2006 Oct 26.PMID: 17095221 [PubMed - indexed for MEDLINE]Related articles

    42.

    Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.

    Mina L, Soule SE, Badve S, Baehner FL, Baker J, Cronin M, Watson D, Liu ML, Sledge GW Jr, Shak S, Miller KD.

    Breast Cancer Res Treat. 2007 Jun;103(2):197-208. Epub 2006 Oct 13.PMID: 17039265 [PubMed - indexed for MEDLINE]Related articles

    43.

    Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.

    James J, Murry DJ, Treston AM, Storniolo AM, Sledge GW, Sidor C, Miller KD.

    Invest New Drugs. 2007 Feb;25(1):41-8. Epub 2006 Sep 13.PMID: 16969706 [PubMed - indexed for MEDLINE]Related articles

    44.

    Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agents.

    Wang M, Gao M, Mock BH, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

    Bioorg Med Chem. 2006 Dec 15;14(24):8599-607. Epub 2006 Sep 8.PMID: 16962783 [PubMed - indexed for MEDLINE]Related articles

    45.

    Synthesis of radiolabeled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers.

    Gao M, Wang M, Miller KD, Sledge GW, Hutchins GD, Zheng QH.

    Bioorg Med Chem Lett. 2006 Nov 15;16(22):5767-72. Epub 2006 Sep 6.PMID: 16950622 [PubMed - indexed for MEDLINE]Related articles

    46.

    Where next for China? Doctors' consciences are called on.

    Miller KD.

    BMJ. 2006 Sep 2;333(7566):500. No abstract available. PMID: 16946347 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.

    Shanmugam R, Jayaprakasan V, Gokmen-Polar Y, Kelich S, Miller KD, Yip-Schneider M, Cheng L, Bhat-Nakshatri P, Sledge GW Jr, Nakshatri H, Zheng QH, Miller MA, DeGrado T, Hutchins GD, Sweeney CJ.

    Prostate. 2006 Oct 1;66(14):1498-511.PMID: 16921510 [PubMed - indexed for MEDLINE]Related articles

    48.

    Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.

    Hochreiter AE, Xiao H, Goldblatt EM, Gryaznov SM, Miller KD, Badve S, Sledge GW, Herbert BS.

    Clin Cancer Res. 2006 May 15;12(10):3184-92.PMID: 16707619 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase.

    Wang JQ, Gao M, Miller KD, Sledge GW, Zheng QH.

    Bioorg Med Chem Lett. 2006 Aug 1;16(15):4102-6. Epub 2006 May 11.PMID: 16697188 [PubMed - indexed for MEDLINE]Related articles

    50.

    Adaptive filtering enhances information transmission in visual cortex.

    Sharpee TO, Sugihara H, Kurgansky AV, Rebrik SP, Stryker MP, Miller KD.

    Nature. 2006 Feb 23;439(7079):936-42.PMID: 16495990 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...